People with active cancer undergoing endovascular treatment for acute ischemic stroke have worse 90-day functional outcomes than those without cancer.
Why this matters
People with cancer are at increased risk of acute ischemic stroke soon after diagnosis. Due to contraindications for other options, endovascular treatment is often the only suitable treatment modality in these individuals, but data on short- and long-term outcomes after this procedure in this population are lacking.
This novel study highlights that those with comorbid active cancer have poor functional outcomes and increased mortality risk, suggesting that this population need individualized, intensified management following endovascular treatment.